Monday, June 18, 2012

ImmunoCellular Therapeutics Ltd. (IMUC) to Be Added to Russell Indexes

ImmunoCellular Therapeutics is a clinical-stage company that is developing immune-based therapies to diagnose and treat brain and other cancers. The company has begun a Phase II trial of its lead product candidate, ICT-107, which is a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma.

The company announced today that it is scheduled to join the US broad market Russell 3000, Russell Global, and Russell Microcap Indexes when Russell Investments reconstitutes its comprehensive set of US and global equity indexes on June 25, 2012. This is according to a list of additions posted on June 8 on the Russell website at www.russell.com/indexes. The Russell 3000 index serves as the US component for the Russell Global index.

The Russell Indexes are widely used by investment managers and institutional investors for index funds and as industry-wide benchmarks for both passive and active investment strategies. According to Russell Investments, an industry-leading $3.9 trillion in assets are currently benchmarked to the various Russell indexes.

ImmunoCellular considers the imminent move of its stock into the Russell indexes to be an important step in the company’s efforts to increase liquidity in its stock and broaden its investor base among major institutional investors. It believes the timing of its inclusion into the indexes is ideal as it should increase investor awareness ahead of the clinical results from its Phase II trial of ICT-107.

To learn more about ImmunoCellular Therapeutics and its ICT-107 product candidate, please visit the company’s website at www.imuc.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: